Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark DeBenedette

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|June 30, 2023
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinomaMark DeBenedette, Alicia Gamble, Marcus Norris, et al.
Transplantation|November 16, 2010
Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenaseZhu Lan, Wei Ge, Jacqueline Arp, et al.
Transplantation|November 17, 2010
Prevention of chronic renal allograft rejection by soluble CD83Zhu Lan, Dameng Lian, Weihua Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cellsCaitlin Hammond, Yonghong Shi, Jenny Mena, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 12, 2016
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialJeffrey M Jacobson, Jean-Pierre Routy, Seth Welles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell CarcinomaRobert A Figlin, Nizar M Tannir, Robert G Uzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancerHoward L Kaufman, Heinz-Josef Lenz, John Marshall, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|June 30, 2023
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinomaMark DeBenedette, Alicia Gamble, Marcus Norris, et al.
Transplantation|November 16, 2010
Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenaseZhu Lan, Wei Ge, Jacqueline Arp, et al.
Transplantation|November 17, 2010
Prevention of chronic renal allograft rejection by soluble CD83Zhu Lan, Dameng Lian, Weihua Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cellsCaitlin Hammond, Yonghong Shi, Jenny Mena, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 12, 2016
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialJeffrey M Jacobson, Jean-Pierre Routy, Seth Welles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell CarcinomaRobert A Figlin, Nizar M Tannir, Robert G Uzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancerHoward L Kaufman, Heinz-Josef Lenz, John Marshall, et al.
Pageof 1